Morphine shortage mounting for palliative patients, Pharmacy Connect finance presenter, Mayne Pharma settles class action, NSW Health’s reminder, and more
Click here to download Pharmacy Daily for Friday 12th July 2024
Morphine shortage mounting for palliative patients, Pharmacy Connect finance presenter, Mayne Pharma settles class action, NSW Health’s reminder, and more
Click here to download Pharmacy Daily for Friday 12th July 2024
SIGMA Healthcare Limited’s share price has surged this week, reaching $2.06, up from $1.46 seven days ago.
JARDIANCE (empagliflozin) has become the first oral treatment to be available on private script for type 2 diabetes (T2D) in children and adolescents, since metformin was indicated for use in this growing patient group.
PRICELINE is set to undergo a rebrand next month to reflect its strategy combining beauty with health expertise and value.
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.